Your about page summarizes your history, values, and mission — all in one place. That’s a tall order for just a few paragraphs. If...

Industry publications have been reporting that an increasing number of companies have begun using “precision fermentation” to produce a variety of high-value food ingredients,...

There is an ongoing trend of people turning away from alcoholic beverages, with several individuals seemingly making vows to stop alcoholic drinks consumption heading...

With 80 years of experience and the best standards in the world, Holle is one of the most established producers of infant formula in...

Hundreds of millions of people take vitamins to supplement their health, yet few have a clue about what each capsule, tablet or gummy contains...

Terpenes, after cannabinoids, are the best-known compounds found in cannabis. Along with their potential medicinal effects, they’re primarily responsible for different aromas and flavours...

As winter approaches, many species of animals — from bears and squirrels to parasitic wasps and a few lucky humans — hunker down for...

Gut health is one of those things that affects much more than one area of your body.  While your stomach is probably not the...

The stomach and the brain have an interesting connection. The stomach is one of the first places to signal anxiety or excitement, with the...

HONG KONG, Mar 23, 2022 - (ACN Newswire) - Kingworld Medicines Group Limited (stock code: 01110.HK), a leading omni-channel enterprise providing greater health products and services in China, issued today a positive profit alert as it expects to record an approximately 155% to 160% increase in profit attributable to owners of the Company for 2021, as compared to RMB11.7 million for 2020.

The positive profit alert was based on preliminary assessment of the unaudited consolidated management accounts of the Group for 2021 and information currently available to the Board. The Board attributes the increase in profit mainly to the market recovering from the COVID-19 pandemic outbreak pushing up the turnover and gross profit of imported branded pharmaceutical and healthcare products distributed in China in 2021 by approximately 45% to 50% and approximately 65% to 70%, respectively, against the previous year. The management of the Company also adopted effective measures against the COVID-19 pandemic outbreak to reduce costs and improve efficiency, thus enhancing the Company's overall competitiveness.

Shenzhen Dong Di Xin Technology Company Limited, Kingworld Medicines' non-wholly owned subsidiary, is a manufacturer producing various medical devices including infrared thermometers. Affected by a drop in sales of anti-Pandemic devices, the company is expected to record an approximately 34% to 39% decrease in profit for 2021 as compared with the previous year.

About Kingworld Medicines Group Limited
Kingworld Medicines (stock code: 01110.HK) has devoted more than 20 years to developing a comprehensive greater health industrial supply chain system. Its business covers over 34 provinces and municipalities in China, and it is among the Top 100 Import Enterprises of Pharmaceutical and Healthcare Products and Top 5 Sales of Imported Chinese Patent Medicine in the country. In-keeping with the new normal of consumption upgrade, it has constructed a complete online and offline new retail ecosystem. Its subsidiary Shenzhen Kingworld Medicines is a reputed distributor of branded pharmaceutical and healthcare products imported from overseas, including Nin Jiom Loquat Herbal Cough Syrup, Taiko Seirogan, Kingworld Imada Red Flower Oil, and Culturelle probiotics from the United States, etc., in the China market.

For further information, please visit http://www.kingworld.com.cn .



Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comKingworld Medicines Group Limited (stock code: 01110.HK), a leading omni-channel enterprise providing greater health products and services in China, issued today a positive profit alert as it expects to record an approximately 155% to 160% increase in profit attributable to owners of the Company for 2021, as compared to RMB11.7 million for 2020.

DENVER — HempFusion Wellness Inc. (TSX:CBD.U) (OTCQB:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness company offering premium probiotic supplements and products containing CBD, is pleased to announce […]

Rochester, NY – Karma Water is proud to announce that Karma CBD Water was named the 2022 Best New CBD Beverage in the 14th annual BrandSpark Best New Product Awards. The […]